An association between neuropeptide Y levels and leukocyte subsets in stress-exacerbated asthmatic mice

Neuropeptides

Volumn 57, Issue , 2016, Pages 53-58

  Lu, Yanxia ^a   Ho, Roger Chun Man ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Airway inflammation; Asthma; Cell infiltration; Neuropeptide Y; Stress

Indexed keywords

CORTICOSTERONE; NEUROPEPTIDE Y;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL COUNT; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOLOGY; ENZYME IMMUNOASSAY; EOSINOPHIL; INFLAMMATORY CELL; LEUKOCYTE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; COMPLICATION; DISEASE MODEL; INFLAMMATION; LEUKOCYTE COUNT; MENTAL STRESS; PATHOLOGY;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CORTICOSTERONE; DISEASE MODELS, ANIMAL; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; STRESS, PSYCHOLOGICAL;

EID: 84949032539     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2015.11.091     Document Type: Article

References (60)

1. Adcock I.M., Caramori G., Chung K.F. New targets for drug development in asthma. Lancet 2008, 372:1073-1087.
2. Aldrich M.C., Rodriguez-Santana J.R., Rodriguez-Cintron W., Beckman K., Eng C., Avila P.C., Burchard E.G. Genetic variation in neuropeptide Y ( NPY) gene is associated with asthma and asthma severity, D21. GENETICS OF AIRWAY DISEASES II 2009, A5431. American Thoracic Society.
3. Augustyniak D., Nowak J., Lundy F.T. Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential. Curr. Protein Pept. Sci. 2012, 13:723-738.
4. Azzawi M., Johnston P.W., Majumdar S., Kay A.B., Jeffery P.K. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 1992, 145:1477-1482.
5. Barrett N.A., Austen K.F. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 2009, 31:425-437.
6. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P., et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990, 323:1033-1039.
7. Bradley B.L., Azzawi M., Jacobson M., Assoufi B., Collins J.V., Irani A.M., Schwartz L.B., Durham S.R., Jeffery P.K., Kay A.B. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 1991, 88:661-674.
8. Carlson D.E., Le W., Chiu W.C., Hoffman G.E. Messenger RNA for neuropeptide Y in the arcuate nucleus increases in parallel with plasma adrenocorticotropin during sepsis in the rat. Neurosci. Lett. 2009, 452:146-150.
9. Chandrasekharan B., Bala V., Kolachala V.L., Vijay-Kumar M., Jones D., Gewirtz A.T., Sitaraman S.V., Srinivasan S. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS One 2008, 3.
10. Chandrasekharan B., Nezami B.G., Srinivasan S. Emerging neuropeptide targets in inflammation: NPY and VIP. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304:G949-G957.
11. Chen E., Miller G.E. Stress and inflammation in exacerbations of asthma. Brain Behav. Immun. 2007, 21:993-999.
12. Christiansen S.H., Olesen M.V., Gotzsche C.R., Woldbye D.P. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice. Neuropeptides 2014, 48:335-344.
13. Claman D.M., Boushey H.A., Liu J., Wong H., Fahy J.V. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 1994, 94:861-869.
14. Czaja K., Kaleczyc J., Sienkiewicz W., Lakomy M. The influence of experimental ileitis on the neuropeptide coding of enteric neurons in the pig. Pol. J. Vet. Sci. 2005, 8:155-163.
15. Decressac M., Wright B., David B., Tyers P., Jaber M., Barker R.A., Gaillard A. Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 2011, 21:233-238.
16. Dimitrijevic M., Stanojevic S. The intriguing mission of neuropeptide Y in the immune system. Amino Acids 2013, 45:41-53.
17. Draijer C., Robbe P., Boorsma C.E., Hylkema M.N., Melgert B.N. Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. Mediat. Inflamm. 2013 2013, 632049.
18. Duan W., Chan J.H., Wong C.H., Leung B.P., Wong W.S. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J. Immunol. 2004, 172:7053-7059.
19. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
20. Farzi A., Reichmann F., Holzer P. The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour. Acta Physiol (Oxf.) 2015, 213:603-627.
21. Hammad H., Chieppa M., Perros F., Willart M.A., Germain R.N., Lambrecht B.N. House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat. Med. 2009, 15:410-416.
22. Hassani H., Lucas G., Rozell B., Ernfors P. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G550-G556.
23. Iwasa T., Matsuzaki T., Kinouchi R., Fujisawa S., Murakami M., Kiyokawa M., Kuwahara A., Yasui T., Irahara M. Neonatal LPS injection alters the body weight regulation systems of rats under non-stress and immune stress conditions. Int. J. Dev. Neurosci. 2010, 28:119-124.
24. Jaakkola U., Kakko T., Juonala M., Lehtimaki T., Viikari J., Jaaskelainen A.E., Mononen N., Kahonen M., Koskinen T., Keltikangas-Jarvinen L., Raitakari O., Kallio J. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects-the cardiovascular risk in young Finns study. Neuropeptides 2012, 46:321-328.
25. Jaaskelainen A.E., Seppala S., Kakko T., Jaakkola U., Kallio J. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice. Neuropeptides 2013, 47:67-73.
26. Joachim R.A., Quarcoo D., Arck P.C., Herz U., Renz H., Klapp B.F. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom. Med. 2003, 65:811-815.
27. Kawamura N., Tamura H., Obana S., Wenner M., Ishikawa T., Nakata A., Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 1998, 5:9-15.
28. Kim Y.W., Kim K.H., Ahn D.K., Kim H.S., Kim J.Y., Lee D.C., Park S.Y. Time-course changes of hormones and cytokines by lipopolysaccharide and its relation with anorexia. J. Physiol. Sci. 2007, 57:159-165.
29. Kuo L.E., Kitlinska J.B., Tilan J.U., Li L., Baker S.B., Johnson M.D., Lee E.W., Burnett M.S., Fricke S.T., Kvetnansky R., Herzog H., Zukowska Z. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 2007, 13:803-811.
30. Kuo L.E., Czarnecka M., Kitlinska J.B., Tilan J.U., Kvetnansky R., Zukowska Z. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 2008, 1148:232-237.
31. Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr. Opin. Pharmacol. 2008, 8:460-471.
32. Liu L.Y., Coe C.L., Swenson C.A., Kelly E.A., Kita H., Busse W.W. School examinations enhance airway inflammation to antigen challenge. Am. J. Respir. Crit. Care Med. 2002, 165:1062-1067.
33. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., Djukanovic R. The relationship between airways inflammation and asthma severity. Am. J. Respir. Crit. Care Med. 2000, 161:9-16.
34. Macia L., Rao P.T., Wheway J., Sierro F., Mackay F., Herzog H. Y1 signalling has a critical role in allergic airway inflammation. Immunol. Cell Biol. 2011, 89:882-888.
35. Macia L., Yulyaningsih E., Pangon L., Nguyen A.D., Lin S., Shi Y.C., Zhang L., Bijker M., Grey S., Mackay F., Herzog H., Sainsbury A. Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity. Diabetes 2012, 61:3228-3238.
36. Makinde T.O., Steininger R., Agrawal D.K. NPY and NPY receptors in airway structural and inflammatory cells in allergic asthma. Exp. Mol. Pathol. 2013, 94:45-50.
37. Malva J.O., Xapelli S., Baptista S., Valero J., Agasse F., Ferreira R., Silva A.P. Multifaces of neuropeptide Y in the brain-neuroprotection, neurogenesis and neuroinflammation. Neuropeptides 2012, 46:299-308.
38. Morgan C.A., Wang S., Mason J., Southwick S.M., Fox P., Hazlett G., Charney D.S., Greenfield G. Hormone profiles in humans experiencing military survival training. Biol. Psychiatry 2000, 47:891-901.
39. Mpouzika M.D., Papathanassoglou E.D., Giannakopoulou M., Bozas E., Middleton N., Boti S., Patiraki E.I., Karabinis A. Altered serum stress neuropeptide levels in critically ill individuals and associations with lymphocyte populations. Neuropeptides 2013, 47:25-36.
40. Muller T., Vieira R.P., Grimm M., Durk T., Cicko S., Zeiser R., Jakob T., Martin S.F., Blumenthal B., Sorichter S., Ferrari D., Di Virgillio F., Idzko M. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol. 2011, 44:456-464.
41. Painsipp E., Herzog H., Sperk G., Holzer P. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br. J. Pharmacol. 2011, 163:1302-1314.
42. Paiva S.P.C., Veloso C.A., Campos F.F.C., Carneiro M.M., Tilan J.U., Wang H., Umans J.G., Zukowska Z., Kitlinska J. Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease. Neuropeptides 2016, 55:127-135.
43. Pankajakshan D., Jia G., Pipinos I., Tyndall S.H., Agrawal D.K. Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines. Exp. Mol. Pathol. 2011, 90:280-286.
44. Qiu H.N., Wong C.K., Dong J., Lam C.W., Cai Z. Effect of tumor necrosis factor family member LIGHT (TNFSF14) on the activation of basophils and eosinophils interacting with bronchial epithelial cells. Mediat. Inflamm. 2014, 2014:136463.
45. Reichmann F., Holzer P. Neuropeptide Y: A stressful review. Neuropeptides 2016, 55:99-109.
46. Rojczyk E., Palasz A., Wiaderkiewicz R. Effect of short and long-term treatment with antipsychotics on orexigenic/anorexigenic neuropeptides expression in the rat hypothalamus. Neuropeptides 2015, 51:31-42.
47. Sandberg S., Paton J.Y., Ahola S., McCann D.C., McGuinness D., Hillary C.R., Oja H. The role of acute and chronic stress in asthma attacks in children. Lancet 2000, 356:982-987.
48. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004, 130:601-630.
49. Singer K., Morris D.L., Oatmen K.E., Wang T., DelProposto J., Mergian T., Cho K.W., Lumeng C.N. Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation. PLoS One 2013, 8.
50. Stogner K.A., Holmes P.V. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur. J. Pharmacol. 2000, 387:R9-10.
51. Tasan R.O., Verma D., Wood J., Lach G., Hörmer B., de Lima T.C.M., Herzog H., Sperk G. The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides 2016, 55:111-126.
52. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., Palmiter R.D., Cadet J.L. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J. Neurosci. 2005, 25:5273-5279.
53. Uzkeser H., Cadirci E., Halici Z., Odabasoglu F., Polat B., Yuksel T.N., Ozaltin S., Atalay F. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism. Mediat. Inflamm. 2012, 2012:438912.
54. Veres T.Z., Rochlitzer S., Braun A. The role of neuro-immune cross-talk in the regulation of inflammation and remodelling in asthma. Pharmacol. Ther. 2009, 122:203-214.
55. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.V., Kay A.B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 1988, 137:62-69.
56. Wheway J., Herzog H., Mackay F. NPY and receptors in immune and inflammatory diseases. Curr. Top. Med. Chem. 2007, 7:1743-1752.
57. Wu Z.X., Benders K.B., Hunter D.D., Dey R.D. Early postnatal exposure of mice to side-steam tobacco smoke increases neuropeptide Y in lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 302:L152-L159.
58. Xu X., Guo F., He Q., Cai X., Min D., Wang Q., Wang S., Tian L., Cai J., Zhao Y. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats. Neuropeptides 2014, 48:97-105.
59. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.
60. Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann. N. Y. Acad. Sci. 1995, 771:219-233.